<DOC>
	<DOCNO>NCT00699374</DOCNO>
	<brief_summary>The study evaluate efficacy safety sunitinib ( Arm A ) , give 37.5 mg orally daily , compare sorafenib ( Arm B ) , give orally 400 mg twice daily , patient inoperable liver cancer . A total number 1200 patient enrol , 600 Arm A 600 Arm B . Study treatment may adjust base patient tolerance . give disease progression , occurrence unacceptable toxicity , withdrawal criterion meet . After discontinuation study treatment , patient follow order collect information antineoplastic therapy survival .</brief_summary>
	<brief_title>Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer</brief_title>
	<detailed_description>This study terminate April 22th , 2010 , base high incidence serious adverse event sunitinib arm compare sorafenib arm , fact sunitinib meet criterion demonstrate either superior non-inferior sorafenib survival patient advance hepatocellular cancer . Patients sunitinib judge investigator receive clinical benefit may choose remain study continue treatment sunitinib clinical benefit per investigator 's judgment .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Histologicallyconfirmed diagnosis hepatocellular carcinoma presence measurable disease radiographic image ChildPugh class A ECOG PS 0 1 adequate organ function . Prior treatment systemic treatment hepatocellular carcinoma prior local treatment within 4 week entry presence clinically relevant ascites severe hemorrhage &lt; 4 week start study treatment know HIV serious acute chronic illness current treatment another clinical trial pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>sunitinib</keyword>
	<keyword>phase 3</keyword>
	<keyword>randomize</keyword>
	<keyword>hepatocellular</keyword>
	<keyword>liver</keyword>
</DOC>